Literature DB >> 21839139

Diepoxybutane interstrand cross-links induce DNA bending.

Julie T Millard1, Erin E McGowan, Sharonda Q Bradley.   

Abstract

The bifunctional alkylating agent 1,2,3,4-diepoxybutane (DEB) is thought to be a major contributor to the carcinogenicity of 1,3-butadiene, from which it is derived in vivo. DEB forms DNA interstrand cross-links primarily between distal deoxyguanosine residues at the duplex sequence 5'-GNC. In order for the short butanediol tether to span this distance, distortion of the DNA target has been postulated. We determined that the electrophoretic mobility of ligated DNA oligomers containing DEB cross-links was retarded in comparison with control, uncross-linked DNA. Our data are consistent with DNA bending of ∼34° per lesion towards the major groove.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21839139      PMCID: PMC3236281          DOI: 10.1016/j.biochi.2011.07.030

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  27 in total

1.  Ecteinascidin 743: a minor groove alkylator that bends DNA toward the major groove.

Authors:  M Zewail-Foote; L H Hurley
Journal:  J Med Chem       Date:  1999-07-15       Impact factor: 7.446

Review 2.  DNA bending induced by covalently bound drugs. Gel electrophoresis and chemical probe studies.

Authors:  M Leng
Journal:  Biophys Chem       Date:  1990-04       Impact factor: 2.352

3.  Synthesis of a duplex oligonucleotide containing a nitrogen mustard interstrand DNA-DNA cross-link.

Authors:  J O Ojwang; D A Grueneberg; E L Loechler
Journal:  Cancer Res       Date:  1989-12-01       Impact factor: 12.701

4.  Calibration of DNA curvature and a unified description of sequence-directed bending.

Authors:  H S Koo; D M Crothers
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

5.  Redox state-dependent interaction of HMGB1 and cisplatin-modified DNA.

Authors:  Semi Park; Stephen J Lippard
Journal:  Biochemistry       Date:  2011-02-28       Impact factor: 3.162

6.  Specific binding of chromosomal protein HMG1 to DNA damaged by the anticancer drug cisplatin.

Authors:  P M Pil; S J Lippard
Journal:  Science       Date:  1992-04-10       Impact factor: 47.728

7.  Steroid hormones induce HMG1 overexpression and sensitize breast cancer cells to cisplatin and carboplatin.

Authors:  Q He; C H Liang; S J Lippard
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

8.  Guanine-adenine DNA cross-linking by 1,2,3,4-diepoxybutane: potential basis for biological activity.

Authors:  Soobong Park; Jacob Hodge; Christopher Anderson; Natalia Tretyakova
Journal:  Chem Res Toxicol       Date:  2004-12       Impact factor: 3.739

9.  Ixr1, a yeast protein that binds to platinated DNA and confers sensitivity to cisplatin.

Authors:  S J Brown; P J Kellett; S J Lippard
Journal:  Science       Date:  1993-07-30       Impact factor: 47.728

10.  The major adduct of the antitumor drug cis-diamminedichloroplatinum(II) with DNA bends the duplex by approximately equal to 40 degrees toward the major groove.

Authors:  J A Rice; D M Crothers; A L Pinto; S J Lippard
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

View more
  3 in total

1.  Loss of Cohesin Subunit Rec8 Switches Rad51 Mediator Dependence in Resistance to Formaldehyde Toxicity in Ustilago maydis.

Authors:  Jeanette H Sutherland; William K Holloman
Journal:  Genetics       Date:  2018-08-06       Impact factor: 4.562

2.  Synthesis of structurally diverse major groove DNA interstrand crosslinks using three different aldehyde precursors.

Authors:  Shivam Mukherjee; Angelo Guainazzi; Orlando D Schärer
Journal:  Nucleic Acids Res       Date:  2014-04-29       Impact factor: 16.971

Review 3.  Cellular response to DNA interstrand crosslinks: the Fanconi anemia pathway.

Authors:  David Lopez-Martinez; Chih-Chao Liang; Martin A Cohn
Journal:  Cell Mol Life Sci       Date:  2016-04-19       Impact factor: 9.261

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.